Nguyen
10-29-2020, 08:11 PM
Genomic alterations in breast cancer: level ofevidence for actionability according to ESMO Scale forClinical Actionability of molecular Targets (ESCAT)
https://www.annalsofoncology.org/article/S0923-7534(19)31092-0/fulltext
Nguyen
https://www.annalsofoncology.org/article/S0923-7534(19)31092-0/fulltext
Nguyen